References
- Imai S, Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010; 31:212-20; PMID:20226541; http://dx.doi.org/10.1016/j.tips.2010.02.003
- Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403:795-800; PMID:10693811
- Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5:147-52; PMID:19173036; http://dx.doi.org/10.7150/ijbs.5.147
- Song NY, Surh YJ. Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci 2012; 1271:10-9; http://dx.doi.org/10.1111/j.1749-6632.2012.06762.x
- Andersen JL, Thompson JW, Lindblom KR, Johnson ES, Yang CS, Lilley LR, Freel CD, Moseley MA, Kornbluth S. A biotin switch-based proteomics approach identifies 14-3-3zeta as a target of Sirt1 in the metabolic regulation of caspase-2. Mol Cell 2011; 43:834-42; PMID:21884983; http://dx.doi.org/10.1016/j.molcel.2011.07.028
- Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV, Dai Y. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci 2010; 6:599-612; PMID:20941378; http://dx.doi.org/10.7150/ijbs.6.599
- Sun L, Fang J. Macromolecular crowding effect is critical for maintaining SIRT1's nuclear localization in cancer cells. Cell Cycle 2016; 15(19):2647-2655; PMID: 27463693; http://dx.doi.org/10.1080/15384101.2016.1211214.